A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma

NCT07520357 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
23
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing GoBroad Hospital